Newsbenzinga
Jasper Closes Kira Deal, Extends Cash Runway
· Published
Article summary
Jasper Therapeutics (JSPR) acquires Kira Pharma & raises $132M, extending its cash runway into 2028. Shares surge 20%+.
An excerpt from the original article.Jasper Therapeutics (JSPR) acquires Kira Pharma & raises $132M, extending its cash runway into 2028. Shares surge 20%+.
An excerpt from the original article.
Comments —
Loading comments…